Insider Transactions Reported by 3 Insiders of Sio Gene Therapies Inc.

Location
New York, NY

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

Sio Gene Therapies Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pavan Cheruvu Chief Executive Officer, Director $288,415 08 Dec 2021
Parag Meswani V. Chief Commercial Officer $47,901 08 Feb 2022
David W. Nassif Interim CEO, CFO, Director 08 Feb 2022

Recent Insider Transactions by Companies or Individuals for Sio Gene Therapies Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Parag Meswani V. Restricted Stock Units Award 153,700 153,700 08 Feb 2022 Direct
David W. Nassif Restricted Stock Units Award 546,500 546,500 08 Feb 2022 Direct
David W. Nassif Common Stock Award 51.6% 17,534 51,538 08 Dec 2021 Direct
David W. Nassif Common Stock Tax liability -12.2% -6,294 45,244 08 Dec 2021 Direct
David W. Nassif Restricted Stock Units Disposed to Issuer -33.3% -17,534 35,066 08 Dec 2021 Direct
Pavan Cheruvu Common Stock Award 20.8% 37,567 217,993 08 Dec 2021 Direct
Pavan Cheruvu Common Stock Tax liability -6.83% -14,884 203,109 08 Dec 2021 Direct
Pavan Cheruvu Restricted Stock Units Disposed to Issuer -33.3% -37,567 75,133 08 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.